Status:
COMPLETED
HELicobacter Pylori Screening in Patients With Acute Myocardial Infarction Pilot Study
Lead Sponsor:
Karolinska Institutet
Conditions:
STEMI - ST Elevation Myocardial Infarction
NSTEMI - Non-ST Segment Elevation MI
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this study is to determine the prevalence of Helicobacter pylori (Hp) infection in patients with myocardial infarction (MI). This is performed to establish the feasibility of a large trial ...
Detailed Description
Despite progressively reduced mortality over the last decades, cardiovascular disease remains the most common cause of death in both men and women in Sweden and the world. In addition to early revascu...
Eligibility Criteria
Inclusion
- Type 1 myocardial infarction (both STEMI and NSTEMI)
Exclusion
- Only concerning UBT (Patients after gastric surgery, with acute gastrointestinal bleeding, suspected gastric infection, or known atrophic gastritis).
Key Trial Info
Start Date :
November 7 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 30 2020
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04289012
Start Date
November 7 2019
End Date
October 30 2020
Last Update
January 12 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Karolinska University Hospital Huddinge
Huddinge, Sweden, 14157
2
Södersjukhuset
Stockholm, Sweden, 11883